Potent transforming activity of the small GTP-binding protein Rit in NIH 3T3 cells: evidence for a role of a p38γ-dependent signaling pathway  by Sakabe, Kaoru et al.
Potent transforming activity of the small GTP-binding protein Rit in
NIH 3T3 cells: evidence for a role of a p38Q-dependent signaling pathway
Kaoru Sakabe, Hidemi Teramoto1, Muriel Zohar2, Babak Behbahani, Hiroshi Miyazaki,
Hiroki Chikumi, J. Silvio Gutkind*
Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 9000 Rockville Pike,
Building 30, Room 212, Bethesda, MD 20892-4330, USA
Received 6 September 2001; revised 12 November 2001; accepted 21 November 2001
First published online 14 December 2001
Edited by Richard Marais
Abstract A novel branch of the Ras family, Rit, was recently
identified. Rit exhibits a distinct C-terminus and effector domain,
and does not activate mitogen-activated protein kinase (MAPK)
but can cooperate with Raf to transform fibroblasts. Here, we
found that when overexpressed, activated mutants of Rit
transform NIH 3T3 cells efficiently, and stimulate p38Q but
not MAPK, p38K, p38L, p38N, or ERK5. Furthermore, we
provide evidence that p38Q activation is required for the ability of
Rit to stimulate gene expression and cellular transformation.
These findings suggest that this unique GTPase stimulates
proliferative pathways distinct from those regulated by other Ras
family members. ß 2002 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
The number of proteins in the Ras superfamily has ex-
panded dramatically over the last decade. Two ras genes,
v-H-ras and v-K-ras, were originally identi¢ed as the trans-
forming sequences in the Harvey and Kirsten sarcoma viruses,
respectively. Presently, more than 50 distinct Ras-like proteins
controlling many aspects of cell growth and cellular behavior
have been identi¢ed in mammals and other organisms. Based
on their protein structure, the Ras superfamily can be divided
into ¢ve subfamilies (see Fig. 1). The Ras family includes
H-Ras, K-Ras, and N-Ras; the Rap subfamily, including
Rap 1A, 1B, 2A and 2B; the R-Ras subfamily; the Ral sub-
family, which includes Ral A and Ral B; and TC21 [1].
More recently, a novel branch of the Ras family, Rit (Ras-
like protein in tissues) has been described. Rit was cloned as a
homolog of Ric (calmodulin-binding Ras-like GTPase) in
Drosophila [2]. This GTPase is highly expressed in most em-
bryonic and adult tissues, and exhibits an e¡ector (G2) do-
main distinct from that of Ras and lacks a C-terminal preny-
lation motif. Although the function of Rit is still unknown, it
was recently shown that Rit can cooperate with Raf to trans-
form NIH 3T3 cells, in spite of its inability to stimulate mi-
togen-activated protein kinase (MAPK) pathways [3]. This
observation prompted us to explore whether Rit may stimu-
late novel proliferative pathways distinct from those regulated
by other members of the Ras superfamily. In this study, we
show that, when overexpressed, Rit is alone su⁄cient to trans-
form NIH 3T3 cells. Furthermore, we found that Rit can
potently activate expression from the c-jun promoter. In
search for the underlying mechanisms, we found that trans-
forming Rit mutants did not stimulate MAPK, p38K, p38L,
p38N, or ERK5. In contrast, we observed that Rit can po-
tently promote the activation of p38Q, a recently identi¢ed
member of the p38 family of MAPKs, and present evidence
that the MKK3/MKK6-p38Q pathway may regulate the trans-
forming ability of this unique Ras-like GTPase.
2. Materials and methods
2.1. Cell lines and transfection
NIH 3T3 cells were maintained in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) (Life Technologies) supplemented with 10% calf
serum, and transfected by the calcium-phosphate precipitation tech-
nique or the Lipofectamine PLUS (Life Technologies) technique fol-
lowing the manufacturer’s instructions, adjusting the total amount of
DNA to 2^5 Wg/plate with vector alone.
2.2. DNA constructs
Expressing plasmids for epitope-tagged MAPKs and GTPases, in-
cluding pCEFL HA-MAPK, pCEFL HA-JNK, pCEFL HA-p38K,
pCEFL HA-p38Q, pCEFL HA-p38N, pCEFL HA-ERK5, pCEFL
AU5-c-H-Ras V12 and pCEFL AU5-RhoA Q63L, were described
previously [4,5]. pCEFL HA-p38L and pCEFL AU5-Rit WT were
obtained upon ampli¢cation of the corresponding coding sequence
by the polymerase chain reaction technique, and subcloned into
pCEFL. pCEFL AU5-Rit 30V and pCEFL AU5-Rit Q79L were ob-
tained by site-directed mutagenesis (Quick Change kit; Stratagene),
replacing glycine-30 and glutamine-79 by valine and leucine, respec-
tively.
2.3. Western blots
Lysates containing approximately 50 Wg of total cellular protein,
anti-HA (12CA5, Covance) immunoprecipitates, or proteins bound
to glutathione-Sepharose beads, (Pharmacia) were analyzed by West-
ern blotting after SDS^polyacrylamide gel electrophoresis. Immuno-
complexes were visualized by enhanced chemiluminescence detection
(Amersham Corp.) using goat anti-mouse or goat anti-rabbit IgGs
coupled to horseradish peroxidase as a secondary antibody (Cappel).
2.4. Kinase assays
MAPK activity in NIH 3T3 cells transfected with an epitope-tagged
MAPK (HA-ERK2, referred in here as HA-MAPK), p38K, p38L,
0014-5793 / 02 / $22.00 ß 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 2 6 4 - 1
*Corresponding author. Fax: (1)-301-402 0823.
E-mail address: sg39v@nih.gov (J.S. Gutkind).
1 Also corresponding author. E-mail: thidemi@nidcr.nih.gov
2 Present address: Bio-Technology General, Kiryat Weizmann, 76326
Rehovot, Israel.
FEBS 25646 21-1-02 Cyaan Magenta Geel Zwart
FEBS 25646 FEBS Letters 511 (2002) 15^20
Fig. 1. Phylogenic family tree of the Ras small GTPase superfamily members (A). Sequence alignment was performed using the Pileup program
from the Genetics Computer Group (GCG) package using the following human protein sequences obtained from the NCBI and the Swiss-Prot
data bank: Rin (NP 008843), Rit (NP 002921), Rap-1A (p10113), Rap-1B (p09526), Rap-2A (p10114), Rap-2B (p17964), H-Ras (p01112),
N-Ras (p01111), K-Ras (p01118), R-Ras (p10301), TC21 (p17082), M-Ras (o14807), Ral A (p11233), Ral B (p11234). B: Focus formation
assay in NIH 3T3 cells transfected with small G proteins. NIH 3T3 cells were transfected by the calcium phosphate technique with pCEFL vec-
tor (control) or with the same expression vector carrying cDNAs for H-Ras V12 (0.05 Wg per plate), RhoA Q63L (0.5 Wg per plate), Rit 30V
(0.5 Wg per plate) and Rit Q79L (0.5 Wg per plate). Cells were cultured for 2 weeks in 5% calf serum, ¢xed, and then stained. C: Actin reorgan-
ization induced by the small GTPases. NIH 3T3 cells were transfected with expression plasmids encoding the small GTP-binding proteins Ras
V12 (1 Wg per plate), Rit 30V (1 Wg per plate), Rit Q79L (1 Wg per plate), and RhoA Q63L (1 Wg per plate). Cells were ¢xed and stained after
48 h with rhodamine-labeled phalloidin to evaluate actin micro¢lament formation. Expression of each small G protein was con¢rmed by immu-
nostaining using an anti-AU5 monoclonal antibody. Similar results were obtained for each experimental plasmid in three to ¢ve independent
experiments.
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p38N, p38Q, JNK, and ERK5 were carried out as previously described
[6,7], using myelin basic protein (Sigma), bacterially expressed GST-
ATF2 (96) or GST-MEF2C fusion proteins as substrate. Samples
were analyzed by SDS^gel electrophoresis on 12% acrylamide gels.
Autoradiography was performed with the aid of an intensifying
screen.
2.5. Reporter gene assays
NIH 3T3 cells were transfected with 1 Wg of each of the di¡erent
expression plasmids together with 0.1 Wg of pJun-Luc reporter plas-
mid. After overnight incubation, the cells were washed with serum-
free DMEM, and kept for 24 h in DMEM supplemented with 20 mM
HEPES. Cells were then lysed using reporter lysis bu¡er (Promega).
2.6. Indirect immuno£uorescence
NIH 3T3 cells were transfected by the Lipofectamine PLUS tech-
nique. Serum-starved transfected NIH 3T3 cells were washed twice
with PBS then ¢xed with 4% formaldehyde with 5% sucrose in PBS
for 10 min and permeabilized with 0.5% Triton X-100 in PBS for 10
min. The cells were incubated with anti-AU5 mAb (Covance) at 10
Wg/ml for 1 h, washed three times with PBS and then with a 1:100
dilution of £uorescein-conjugated goat F(abP)2 IgG anti-mouse (Bio-
source International) and rhodamine-conjugated phalloidin (Molecu-
lar Probes). Coverslips were mounted in Gel-mount (Biomeda Corp.)
containing p-phenylenediamine (ICN) at 1 mg/ml to inhibit photo-
bleaching and viewed using an Axioplan2 £uorescence microscope
(Zeiss). When required, pictures were taken at 40U magni¢cation
using a SPOT digital camera and software (Diagnostic Instruments)
and analyzed using Adobe Photoshop.
2.7. Focus formation of NIH 3T3 cells
Plasmid DNA transfection of NIH 3T3 cells was performed by the
calcium phosphate precipitation technique, and transformed foci were
scored after 2^3 weeks as described [7].
3. Results and discussion
3.1. Focus formation in NIH 3T3 cells by Rit
A dendrogram of the Ras family (Fig. 1A) shows that Rit
de¢nes a distinct subfamily of Ras-related GTPases. Rit pos-
sesses C-terminal sequences not seen in any other Ras family
proteins, which are modi¢ed by farnesyl or geranylgeranyl
Fig. 2. Activation of MAPK pathways by UV and small GTPases. NIH 3T3 cells were transfected by the Lipofectamine PLUS technique with
pCEFL vector (control) or with the same expression vector carrying cDNAs for the designated small GTPases (A) and MAPKs (B) (1 Wg per
plate in each case). Expression of the indicated epitope-tagged molecules was con¢rmed by Western blot analyses. C: In vitro kinase assays on
anti-HA immunoprecipitates were performed in transfected cells, with or without UV stimulation (120 mJ, UV-Stratalinker 1800, Stratagene),
as indicated.
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isoprenoids [2], and exhibits poor sequence conservation in
the Ras e¡ector domain, thus suggesting that this Ras family
member may perform distinct cellular functions. Although its
normal function is still unknown, recent evidence indicates
that Rit can cooperate with other oncogenes to transform cells
[3]. However, this approach did not reveal whether Rit could
control growth-promoting pathways, nor the nature of the
biochemical routes regulated by this GTPase. To explore
whether Rit can itself transform NIH 3T3 cells, we used an
EF-1 (elongation factor 1) promoter driven expression plas-
mid (pCEFL), whose transcription activity is reported to be
stronger than that of the CMV promoter [14].
As shown in Fig. 1B and Table 1, when used as controls
H-Ras V12 and RhoA Q63L were highly transforming, each
eliciting the formation of foci with a characteristically distinct
morphology, being Ras V12 foci larger and di¡use, and Rho
Q63L punctuate and clearly de¢ned [4]. Rit WT did not trans-
form NIH 3T3 cells e¡ectively, but two activated mutants, Rit
Fig. 3. Stimulation of the c-jun promoter activity by small GTPases. A: NIH 3T3 cells were cotransfected with pJLuc (0.1 Wg per plate) and
pcDNA3L-gal (1 Wg per plate) plasmid DNAs together with expression plasmid containing the indicated small G protein (1 Wg per plate).
B: NIH 3T3 cells were cotransfected with pJLuc (0.1 Wg per plate) and pcDNA3L-gal (1 Wg per plate) plasmid DNAs together with expression
plasmid for Rit Q79L (1 Wg per plate) alone or in combination with MEK1 AA or MKK3 AA (1 Wg per plate). Data represent luciferase activ-
ity normalized by the L-galactosidase activity present in each cellular lysate, expressed as fold induction with respect to control cells, and are
the average þ S.E.M. of triplicate samples from a typical experiment which was repeated four to six times. C: NIH 3T3 cells were transfected
with pCEFL vector (control) (1 Wg per plate) or with vectors for MEK1 AA and MKK3 AA together with Rit Q79L and HA-p38Q, as indi-
cated (1 Wg per plate in each case) and subjected to in vitro kinase assays. D: NIH 3T3 cells were transfected with pCEFL vector (control)
(1 Wg per plate) or with the same expression vectors for Rit Q79L (0.5 Wg per plate) (D,E) or Ras V12 (0.05 Wg per plate) (F) alone or in com-
bination with MKK3 AA or MEK1 AA (1 Wg per plate in each case) for focus formation assays.
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30V and Rit Q79L produced the formation of foci, albeit with
a clearly di¡erent e⁄ciency (Table 1). Rit 30V produced few
scattered foci, but Rit Q79L was nearly as transforming as
Rho Q63L, although the morphology of Rit Q79L foci was
more similar to that of H-Ras V12. Thus, this observation
allowed us to begin exploring how this intriguing Ras-related
protein promotes uncontrolled cell growth.
3.2. Rit induces a Ras-like change in the cytoskeleton
To investigate the e¡ects of Rit in inducing actin rearrange-
ment, NIH 3T3 cells were transfected with the AU5-tagged
small GTP-binding proteins H-Ras V12, Rit 30V, Rit Q79L
and RhoA Q63L, and studied by £uorescence microscopy
employing an anti-AU5 antibody to detect the GTPases and
with rhodamine-conjugated phalloidin to directly identify the
¢lamentous actin containing structures. As shown in Fig. 1C,
serum-starved NIH 3T3 cells exhibited very low levels of
stress ¢bers. In contrast, RhoA Q63L overexpression induced
the formation of multiple actin stress ¢bers and enhanced
overall staining for F-actin associated with a contracted cel-
lular morphology, clearly distinguishing transfected cells from
adjacent cells. H-Ras, Rit 30V and Rit Q79L expression, on
the other hand, did not induce stress ¢bers, but provoked
changes in the cellular morphology, which became detached
from the adjacent cells and exhibited membrane extensions in
a stellate shape, with some ru¥e-like structures at their end
that were more remarkable for Rit Q79L.
3.3. Regulation of MAPK, JNK, p38 (K, L, N, Q) and ERK5
kinase by Rit in NIH 3T3 cells
Emerging evidence indicates that many of the biological
functions of small GTP-binding proteins are dependent on
their ability to activate intracellular signaling pathways result-
ing in the stimulation of members of the MAPK superfamily
of serine-threonine kinases [8]. Ras and certain Ras-related
proteins activate ERK1 and ERK2, referred herein as
MAPKs, while Rac and Cdc42 activate the stress activated
protein kinases JNK and p38 [9]. As activated Rit had a
profound biological activity in NIH 3T3 cells, we next exam-
ined whether this GTPase could activate MAPK family mem-
bers in these cells. For these experiments, Ras V12, Rit WT,
Rit 30V and Rit Q79L (Fig. 2A) were co-expressed with epi-
tope-tagged forms of MAPK, JNK p38K, p38L, p38Q, p38N
and ERK5 in NIH 3T3 cells (Fig. 2B). As a general control,
we used UV stimulation, which resulted in the activation of all
MAPKs (Fig. 2C). As expected, Ras stimulated MAPK po-
tently, but did not activate any of the other members of the
MAPK superfamily in these cells. In contrast, Rit did not
stimulate MAPK, as reported [3], nor it activated ERK5,
JNK and the best-studied p38s, p38K and p38L (Fig. 2C).
Rit did not activate p38N, but surprisingly stimulated p38Q
potently. Even wild-type Rit induced a nearly two-fold acti-
vation, which was slightly higher for Rit 30V. Furthermore,
Rit Q79L provoked a remarkable activation of p38Q, which,
of note, correlated well with its enhanced biological activity.
3.4. Rit stimulates c-jun transcription
As p38Q can regulate c-jun expression [7], we next examined
the ability of Ras and Rit to stimulate the activity of the c-jun
promoter (pJLuc) in this cellular system. As shown in Fig. 3A,
Rit activated c-jun promoter potently, while Ras did not en-
hance the expression from this promoter. MKK3 and MKK6
function as upstream activators of the p38 MAPK family [10].
Thus, we asked whether these kinases participate in the acti-
vation of p38Q by Rit, using the expression of a dominant-
negative form of MKK3, MKK3 AA [11], as an approach. As
shown in Fig. 3C, c-jun transcriptional activity was blocked
potently by the dominant-negative MKK3. Similarly, a kinase
de¢cient mutant of MKK6, MKK6 KR [12] was also able to
diminish the activation of the c-jun promoter by Rit (not
shown). In contrast, MEK1 AA, a dominant-negative form
of the upstream activator of the MAPK pathway [13], had no
e¡ect on the expression from the c-jun promoter.
3.5. Inhibition of Rit-induced transformation by a
dominant-negative MKK3
We next examined whether inhibition of p38Q activation can
a¡ect the ability of Rit to transform cells. First, we con¢rmed
that MKK3 AA but not MEK1 AA could prevent p38Q acti-
vation by Rit Q79L in NIH 3T3 cells (Fig. 3C). Furthermore,
focus formation assays revealed that interfering with MKK3
function could diminish dramatically the transforming activity
of Rit (Fig. 3D,E), although under identical conditions the
inactive MKK3 did not a¡ect Ras-induced focus formation
(Fig. 3F). Conversely, a dominant-negative mutant of MEK1
e¡ectively inhibited the transforming Ras pathway, but had a
marginal e¡ect on Rit (Fig. 3E,F).
4. Conclusion
The emerging picture from this study is that Rit can initiate
cytoskeletal changes, c-jun transcription activity, and cellular
transformation when expressed in NIH 3T3, utilizing bio-
chemical routes distinct from those activated by other Ras
family members. Speci¢cally, available evidence suggests that
the p38Q but not the MAPK pathway is required for the
stimulation of the c-jun promoter and cellular transformation
by Rit. Why Rit activates only p38Q is not known, as MKK3
and MKK6 can act upstream of all p38 family members.
Additional factors, such as the presence of speci¢c kinase-ki-
nase recognition sequences [15], the expression of p38-speci¢c
phosphatases, or the existence of sca¡olding molecules favor-
ing the activation of speci¢c kinase modules may help explain
the speci¢c activation of p38Q by Rit. These, as well as addi-
tional possibilities are under current investigation. On the
other hand, prolonged activation of p38Q and other p38 iso-
forms by overexpression of MKK3 and MKK6 did not result
in focus formation or cytoskeletal changes, nor they potenti-
Table 1
Focus-forming activity of wild-type and mutated Rit
DNA construct Focus-forming activity (foci per
Wg of DNA)
pCEF AU5 6 1
pCEF AU5 H-Ras V12 1030 þ 76
pCEF AU5 RhoA Q63L 102 þ 18
pCEF AU5 Rit WT 10 þ 2
pCEF AU5 Rit 30V 22 þ 3
pCEF AU5 Rit Q79L 253 þ 24
Wild-type or mutated Rit cDNAs were subcloned in an expression
vector, pCEF AU5, and 0.05^1 Wg of plasmid DNA was transfected
into NIH 3T3 cells. Cultures were scored for focus formation 2^3
weeks after transfection. Data shown represent mean values of the
number of foci formed per Wg of transfected DNA þ S.E.M. of trip-
licate plates from three independent experiments.
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ated these e¡ects when elicited by Rit (data not shown). Thus,
we can speculate that Rit may utilize additional proliferative
pathways to transform NIH 3T3 cells. Further work will be
required to elucidate fully the nature of the signaling events
regulated by Rit, as well as to unravel the complexity of the
molecular mechanisms whereby this GTPase may promote
aberrant cell growth.
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